High-intensity exercise interventions in cancer survivors: a systematic review exploring the impact on health outcomes Kellie TooheyKate PumpaStuart Semple Review – Cancer Research 05 December 2017 Pages: 1 - 12
The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer Klaus FrieseBernd KostSabine Heublein Original Article – Cancer Research 18 September 2017 Pages: 13 - 19
Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade Akihiro AsaiYasuyoshi MiyataHideki Sakai Original Article – Cancer Research Open access 26 September 2017 Pages: 21 - 31
A revision of the Tokuhashi revised score improves the prognostic ability in patients with metastatic spinal cord compression Søren Schmidt MorgenSidsel FruergaardBenny Dahl Original Article – Cancer Research 06 October 2017 Pages: 33 - 38
Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression Jianfeng WangYunze XuJin Zhang Original Article – Cancer Research 09 October 2017 Pages: 39 - 52
Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck Till Sebastian ClauditzArne BöttcherAdrian Münscher Original Article – Cancer Research 11 October 2017 Pages: 53 - 61
Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16 Beata BiesagaAnna Mucha-MałeckaMarcin Przewoźnik Original Article – Cancer Research Open access 17 October 2017 Pages: 63 - 73
Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern Yukiko MatsuoKazu ShiomiYukitoshi Satoh Original Article – Cancer Research 01 November 2017 Pages: 75 - 87
Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells Kenichiro IshiiIzumi MatsuokaYoshiki Sugimura Original Article – Cancer Research 02 November 2017 Pages: 89 - 98
Cardiovascular effects of Hodgkin’s lymphoma: a review of literature Aasems JacobBragadheeswar ThyagarajanDavid Sharon Review – Clinical Oncology 18 December 2017 Pages: 99 - 107
The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor Akitoshi TakizawaKoji KawaiHiroyuki Nishiyama Original Article – Clinical Oncology 13 September 2017 Pages: 109 - 115
Lung cancer screening with MRI: results of the first screening round Michael Meier-SchroersRami HomsiDaniel Thomas Original Article – Clinical Oncology 20 September 2017 Pages: 117 - 125
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies C. Boglione-KerrienS. PicardA. Petitcollin Original Article – Clinical Oncology 20 September 2017 Pages: 127 - 134
A novel biopsy-related parameter derived from location and relationship of positive cores on standard 12-core trans-rectal ultrasound-guided prostate biopsy: a useful parameter for predicting tumor volume compared to number of positive cores Sangjun YooHwancheol SonHyeon Jeong Original Article – Clinical Oncology 22 September 2017 Pages: 135 - 143
Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database Shenhai WeiJintao TianLimin Liu Original Article – Clinical Oncology 04 October 2017 Pages: 145 - 155
Drug-eluting bead transarterial chemoembolization in the treatment for unresectable soft tissue sarcoma refractory to systemic chemotherapy: a preliminary evaluation of efficacy and safety Jia-yan NiHong-liang SunLin-feng Xu Original Article – Clinical Oncology 09 October 2017 Pages: 157 - 163
Are exon 19 deletions and L858R different in early stage lung adenocarcinoma? Yiliang ZhangYuan MaHaiquan Chen Original Article – Clinical Oncology 12 October 2017 Pages: 165 - 171
Qualitative evaluation of mobile cancer apps with particular attention to the target group, content, and advertising Cathleen BöhmeMarc Baron von OsthoffJutta Hübner Original Article – Clinical Oncology 19 October 2017 Pages: 173 - 181
Can checkpoint inhibitor therapy improve response to chemotherapy? Michael Constantin KirchbergerBastian SchillingLucie Heinzerling Letter to the Editor 24 November 2017 Pages: 183 - 185
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase Juan Luis SteegmannDolors ColomerLuis Felipe Casado-Montero Correction Open access 23 October 2017 Pages: 187 - 188